clinical pharmacology of inhaled anesthetics dr. greg bryson dept of anesthesiology the ottawa...
TRANSCRIPT
Clinical Pharmacology of Inhaled Anesthetics
Dr. Greg BrysonDept of AnesthesiologyThe Ottawa Hospital2012.09.27
Objectives I
• Chemical structure• Structure - function relationships• Physiochemical properties • Definition of MAC• Factors which affect MAC• Mechanism of action • Uptake and Distribution
Objectives II
• Fa/Fi curves, and factors which affect them • Physiological effects of inhalation anesthetics:
– Cardiovascular system– Respiratory system– Central nervous system– Neuromuscular junction– Others
• Metabolism/toxicity of inhalation anesthetics
The reality
• You use these drugs every day • If you don’t know them – no one else does• None of this stuff is “new”• All of it is in the textbooks• Some of it is useful – some is “on the exam” • I can’t cover all of it in 3 hours
Greg’s goals for this lecture
• Inflict my view of what you should know• Put this in a clinical (read: useful) context• Explain that which needs explaining • Leave the memory work to you• Take my daughter to cross country practice
Reference material
• Miller 7th Edition– Chapter 20. Inhaled Anesthetics. Mechanisms
of Action. – Chapter 21. Inhaled Anesthetics. Uptake and
Distribution. – Chapter 22. Pulmonary Pharmacology.– Chapter 23. Cardiovascular Pharmacology.– Chapter 24. Inhaled Anesthetics. Metabolism
and Toxicity.
Fun with chemistry
• Alkanes precipitate arrythmias • Halogenation reduces flammability• Fluorination reduces solubility• Trifluorcarbon groups add stability
Physical characteristics
• Please cram the contents of table 15.1 from Barash 5th Ed the night before the exam. Take home points include:– desflurane boils at 24 OC– halothane is preserved with thymol– vapor pressures are needed for some
exam questions– knowledge of blood:gas partition
coefficients may actually be useful (uptake and distribution)
Partition coefficients
• Represent the relative affinity of a gas for 2 different substances (solubility)
• Measured at equilibrium so partial pressures are equal, but...
• The amounts of gas dissolved in each substance (concentration) aren’t equal.
• The larger the number, the more soluble it is in the first substance
Key Physical Properties
Drug MAC Oil:Gas PC Blood:Gas PC
Nitrous Oxide 105 1.4 0.47
Xenon 71 1.9 0.14
Desflurane 6.0
19 0.45
Sevoflurane 1.71 53 0.65
Enflurane *1.68 *97 1.4
Isoflurane 1.15 90 1.8
Halothane *0.74 *224 2.5Tables 21.1 and 24.1. Miller 7th Ed* Old textbooks on my shelf
Mechanism of action II
• Protein Receptor Hypothesis– ligand-gated ion channels (GABA, glycine,
NMDA-glutamate)– voltage-gated ion channels (Na, K, Ca)– G-proteins (guanine nucleotide)– Protein kinase C
• Site of action– Brain v spinal cord (amnesia v immobility)– Axonal v synaptic– Pre v post synaptic
Minimum alveolar concentration
• Alveolar concentration required to prevent movement in 50% of subjects
• standard stimulus• represents brain concentration• consistent within and between species• Additive• Variants
– BAR (1.7 – 2.0 MAC)– Awake (0.3 -0.5 MAC)
Factors decreasing MAC
• Increasing age (6% per decade)• Hypothermia• Hyponatremia• Hypotension (MAP<50mmHg)• Pregnancy• Hypoxemia (<38 mmHg)• O2 content (<4.3 ml O2/dl)• Metabolic acidosis
• Narcotics • Ketamine• Benzodiazepines• 2 agonists
• LiCO3
• Local anesthetics• ETOH (acute)• And many more...
Table 15.5. Barash 5th Edition
Factors increasing MAC
• Hyperthermia• Chronic ETOH abuse• Hypernatremia• Increased CNS transmitters
– MAOI– Amphetamine– Cocaine – Ephedrine– L-DOPA
Table 15.4. Barash 5th Edition.
Factors with no influence on MAC
• Duration of anesthesia• Sex• Alkalosis• PCO2
• Hypertension• Anemia• Potassium• Magnseium• And others
Uptake and distribution
• Anesthesia depends upon brain partial pressure• Alveolar partial pressure (PA) = Pbrain
• The faster PA approaches the desired level the faster the patient is anesthetized
• PA is a balance between delivery of drug to the alveolus and uptake of that drug into the blood
• Time for an analogy
To induce anesthesia the bucket (PA) must be full. Unfortunately the bucket has a leak (uptake). To fill the bucket you must either (a) pour it in faster (increase delivery) or (b) slow down the leak (decrease uptake).
a
b
Factors influencing uptake
• Solubility (blood:gas pc)• Cardiac output• Alveolar-venous pressure gradient• For those of you who like formulae:
Uptake = • Q • (PA-Pv)/BP
The blood:gas pc is useful, really.
• Anesthesia is related to the partial pressure of the gas in the brain.
• If a drug is dissolved in blood, it isn’t available as a gas
• More molecules of a soluble gas are required to saturate liquid phase before increasing partial pressure
• Speed of onset/offset closely related to solubility• The lower the blood:gas pc - the faster the onset
FA/FI Curves
Agent Blood:Gas PC
Nitrous Oxide 0.47
Desflurane 0.45
Sevoflurane 0.65
Isoflurane 1.8
Methoxyflurane 12
Factors influencing delivery
• Alveolar ventilation• Breathing system
– volume– fresh gas flow
• Inspired partial pressure (PI)– concentration effect– second gas effect
V/Q distribution and uptake
• Ventilation < perfusion (shunt)– blood leaving shunt dilutes PA from normal lung– induction with low solubility agent will be
delayed – little difference with soluble agents (slow
anyway)• Ventilation > perfusion (dead space)
– uptake is decreased which enhances rise in FA
– may speed induction for soluble agents– less difference with low solubility agents (fast
anyway)
Objectives II
• Physiological effects of inhalation anesthetics:– Cardiovascular system– Respiratory system– Central nervous system– Neuromuscular junction– Others
• Metabolism/toxicity of inhalation anesthetics
Effects on organ systems
• Cardiovascular (Ch 23)• Pulmonary (Ch 22)• CNS (Ch 13)• Neuromuscular • Hepatic (Ch 66)• Renal (Ch 45)• Uterine (ch 69)• Miscellaneous
Inhaled anesthetics - CV system
• Effect is hard to quantify• In vitro and in vivo effects often quite different
– Sympathetic stimulation– Baroreceptor reflexes – Animal model vs human subject
• Information provided in this lecture is a broad overview.
• Chapter 23, Miller 7th Ed for details
Myocardial contractility
• All volatile anesthetics are direct myocardial depressants in vitro, including N2O.
• Effect on circulation in vivo modified by effects on pulmonary circulation and sympathetic stimulation.
• Ca++ hemostasis in sarcoplasmic reticulum• As best as we can tell, at 1 MAC anesthetics
depress contractility in the following order – H = E > I = D = S.
Heart rate
• Effects variable and agent-specific– halothane decreases HR– Sevoflurane and enflurane neutral– Desflurane associated with transient tachycardia
• occurs with rapid increases in MAC• associated with increases in serum
catecholamines• similar effect may be seen with isoflurane
Blood pressure
• All decrease BP, except N2O• Effect caused by a combination of
– Vasodilation– Myocardial depression– Decreased CNS tone
• Relative contribution of each is drug dependent
Cardiac output
• Despite myocardial depression cardiac output is well-maintained with isoflurane and desflurane– preservation of heart rate– greater reduction in SVR– preservation of baroreceptor reflexes
Systemic vascular resistance
• All are direct vasodilators, except N2O• relax vascular smooth muscle• cAMP - Ca++and/or nitric oxide involved• variable effects on individual vascular beds
Dysrhytmias
• Halothane potentiates catecholamine-related dysrhythmias
• ED50 of epinehrine producing dysrhythmias at 1.25 MAC– halothane 2.1 g•kg-1
– isoflurane 6.9 g•kg-1
– enflurane 10.9 g•kg-1 – Sevo + Des similar to isoflurane
• Lidocaine doubles ED50 of epinephrine• Children somewhat more resistant
Chapter 2. Stoelting P&P. 2nd Ed Chapter 5. Barash 5th ED
Coronary blood flow
• Isoflurane is a potent coronary vasodilator• In theory, dilation of normal coronary vessels can direct
blood flow away from stenotic coronaries• Steal-prone anatomy
– total occlusion of 1 major coronary vessel– collateral perfusion with 90% stenosis
• In practice, doesn’t seem to be a problem
Myocardial protection
• Ischemic preconditioning• Volatiles appear able to replicate the effect• Activation of mitochondrial KATP channels
– maintain Ca++ hemostasis– prevent mitochondrial Ca++ overload
• Inhibition of adenosine 1 (A1) receptors and guanine inhibitory (Gi) proteins abolish protection
• Free radical scavenging (ROS)
Respiratory system
• Volatile anesthetics affect all aspects of RS• With exception of bronchodilation, none good.• For all the gory details (Chapter 22. Miller 7th
Ed)
Bronchial musculature
• Reduce vagal tone• Direct relaxation
– decreased intracellular Ca++
– decreased sensitivity to Ca++
• When bronchospastic, a dose dependent reduction in Raw occurs with most agents
• Exception is Xenon– Increased viscosity causes increased Raw
Mucociliary function + surfactant
• Volatile anesthetics decrease ciliary beat• Decreased mucus clearance• Decreased production of phosphatidylcholine
– PC used to make surfactant– occurs in as little as 4 hours– reversible in 2 hours
Pulmonary blood flow
• Intrinsic vasodilators• Hypoxic pulmonary vasoconstriction• Intrinsic changes in HPV confounded by
– changes in cardiac output– pulmonary artery pressure– position
• Shunt and PO2 appear unchanged in studies of inhaled anesthetics during one lung ventilation
Control of ventilation
• All decrease tidal volume• Most increase frequency• Net effect is:
– decrease minute ventilation– increased PaCO2 (E>D=I>S=H)
• Xenon appears to do the opposite• Decreased sensitivity and response to
– Hypoxia– Hypercarbia– Inspiratory and expiratory loads
Lung volumes
• Decreased FRC– decreased intercostal muscle activity– phasic expiratory muscle activity
• Cephalad displacement of dependent diaphragm
• Dependent atelectasis
Enclosed Air Spaces
• N20 leaves blood 34x more than N2 absorbed• Sure, other agents are more soluble but we don’t give
them at 70% end-tidal concentration• distension of closed air spaces• 70% N2O will double a pneumo in 10 minutes
Agent Blood:Gas PCNitrous Oxide 0.47Nitrogen 0.014
Fig 21-13 Miller 7th Ed.
Central nervous system
• Increase cerebral blood flow (halo worst)• Increase ICP – related to increase in CBF• Decreased CMRO2 – uncoupled
.• Decreased frequency - increased voltage on EEG• 2 MAC enflurane increases seizure activity• Decreased amplitude - increased latency on SSEP
Hepatic
• Volatile anesthetics increase hepatic arterial blood flow – decrease portal blood flow
• Halothane is the exception – decreases arterial flow.
• Clearance of drugs decreased in keeping with alteration in hepatic blood flow
Renal
• Dose-dependent decreases in– renal blood flow– glomerular filtration rate– urine output
• Related to changes in CO and BP not ADH
Obstetrical
• N2O has no effect• Halogenated volatiles lead to dose-dependent
– uterine relaxation– reductions in uterine blood flow
.
Metabolism of inhaled anesthetics
• Fairly small component of elimination• Occurs at cytochrome p450• Inducible• Oxidative
– o-dealkylation– dehalogenation– epoxidation
• Reductive– occurs only with halothane in hypoxic
conditions
Three determinants of metabolism
• Chemical structure– ether bond– carbon-halogen bond
• Hepatic enzyme activity– Cytochrome P450 (CP2E1– Inducible
• Blood concentration
Metabolism of inhaled anesthetics II
Table 15-1. Barash 5th Edition.
Agent % MetabolizedHalothane 20Sevoflurane 2-5Enflurane 2.4Isoflurane 0.2Desflurane 0.02Nitrous Oxide 0.004Xenon 0.000
Hepatic toxicity
• Hepatotoxicity comes in 2 forms• mild, transient, postoperative increase in LFTs
– ? due to transient hypoxia ± reductive metabolites
• massive hepatic necrosis– oxidative metabolite (TFA) binds to hepatocyte– repeat exposure leads to immune-mediated
necrosis• Largely a disorder of halothane (metabolism)• Some evidence for other volatiles and HCFCs
Fluoride nephrotxicity
• Oxidative metabolism releases inorganic fluoride• Toxic at serum concentrations 50 mol/l• F- opposes ADH leading to polyuria• Duration and intensity of exposure important
– methoxyflurane 2.5 MAC-hours (renal metabolism)
– enflurane 9.6 MAC-hours– sevoflurane ?
Sevofluane and compound A
• Reaction with alkaline, hot, C02 absorbents• FGF related to heating of absorbent• Baralyme > soda lime• 25 – 50 ppm yields ATN in rats• Rats have 20 – 30 times more -lyase
– thionoacyl fluoride metabolite is toxic • Human studies have not demonstrated ATN
Carbon monoxide
• Interaction with dry, basic CO2 absorbent• Monday morning syndrome• All volatiles generate CO
– desflurane>enflurane>isoflurane>>>sevo+halothane
– Baralyme (20% BaOH) > soda lime (CaOH, NaOH)– We use ???
Miscellaneous
• N2O-related myelosupression if >12 hr exposure– inhibition of methionine-synthetase– megaloblastic anemia
• Inhaled anesthetics, N2O in particular, decrease leukocyte function
• Teratogenesis with prolonged exposure in rats • Increased risk (RR = 1.3) of spontaneous
abortion with chronic exposure to N20